Incidence, risk factors, prognosis, and health-related quality of life after stroke in a low-resource community in Chile (ÑANDU): a prospective population-based study thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.
Denise Smith joins board of directors of Northwest Bank By: IBR Staff December 28, 2020 Comments Off on Denise Smith joins board of directors of Northwest Bank
Denise Smith
Northwest Bank and its holding company, Western Capital Corporation, announced that Denise “Dee Dee” Smith has joined the board of directors for both companies. Smith is a resident and native of Boise. She serves as the managing director of TCS Family Interests and the Smith Family Charitable Foundation.
Prior to this role, Smith held a thirteen-year career in pharmaceutical sales. Most recently, she was a senior account manager for Bristol Meyers Squibb’s immune-oncology division. She also worked in both Johnson & Johnson’s and Novartis’ neuroscience divisions. Earlier in her career, Smith worked in the technology field managing strategic partnerships with startup business analytics software company ProClarity Corporation. Strategic partners included Microsoft, Proctor & Gamble and Uni
Shares of pharmaceutical companies were in focus on Monday with Nifty Pharma index hitting a fresh record high of 12,836 on the National Stock Exchange (NSE) in an otherwise subdued market. Cipla, Cadila Healthcare, Lupin, Sun Pharmaceutical Industries and Aurobindo Pharma from the Nifty Pharma index were up in the range of 1 per cent to 2 per cent on the NSE. Meanwhile, Marksans Pharma, Suven Pharma, Novartis, Indoco Remedies, Glenmark Pharmaceuticals, Dr. Lal PathLabs, RPG Life Sciences, Strides Pharma Science and Laurus Labs from the S&P BSE Healthcare index were up between 2 per cent and 5 per cent. In comparison, the benchmark indices, Nifty50 and S&P BSE Sensex were trading flat at 13,742 points and 46,999 points, respectively, at 10:02 am.
Glioblastoma Multiforme (GBM) Treatments Advancing as FDA Steps Up Measures Due to Rising Incidences
PALM BEACH, Fla., Dec. 17, 2020 /PRNewswire/ Glioblastoma multiforme (GBM) is the most common and aggressive malignant brain tumor in humans that involves glial cells. GBM is present in two variants namely, giant cell glioblastoma and gliosarcoma. Gliomas are tumors arising from glial cells and may occur in the spinal cord or the brain, the latter being more common. Gliomas are the most common type of brain tumor and can be either supratentorial or infratentorial. Seizure, nausea, headache, hemiparesis and memory loss are some of the common symptoms observed in the patients suffering from GBM. GBM is most commonly found in male with the age of 65 years and above. Increasing habits of alcohol consumption, changing lifestyle and increasing incidence of seizure are some of the drivers for the growth of GBM market. GBM is generally treated by first surgically removing the tumor then t
MiMedx: Raising Our PT To $31 On New Findings That Indicate Amniofix Will Be A Blockbuster, Game-Changing Osteoarthritis Treatment (NASDAQ:MDXG) seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.